Status:
COMPLETED
Long-term Evaluation of Primary Trapeziectomy and Placement of a RegJoint Implant in the Treatment of Rhizarthrosis
Lead Sponsor:
Brugmann University Hospital
Conditions:
Rhizarthrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In a society based on the use of everyday tools and objects, the loss of function of one or both thumbs due to Rhizarthrosis can drastically reduce the quality of life. Many patients are refractory to...
Eligibility Criteria
Inclusion
- Adults\> 18 years
- Patients having had a trapeziectomy for more than one year, because of chronic Rhizarthrosis defined by pain and Radiographic Signs, aka articular pinching, bone erosion and potential subluxation of the trapezo-metacarpal joint.
Exclusion
- Surgery less than 1 year ago.
- Concomitant pathology of the thumb or wrist (Recent injury or trauma, Quervain tenosynovitis, Carpal tunnel syndrome, Dupuytren, jumping finger).
- Trapeziectomy secondary to distal prosthesis and scaphoidectomy.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2018
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT03320291
Start Date
November 1 2017
End Date
October 10 2018
Last Update
April 17 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020
2
Clinique du Parc Léopold
Brussels, Belgium, 1040